压力支持通气与T管通气策略对机械通气患者自主呼吸试验后成功拔管的影响:一项随机临床试验
该随机临床试验在西班牙18个重症监护病房纳入1153例机械通气至少24小时、判定可撤机的成人患者,比较30分钟压力支持通气(8 cm H2O)与2小时T管通气两种自主呼吸试验对成功拔管的影响;压力支持组成功拔管率82.3%高于T管组74.0%(差值8.2%,95%CI 3.4%-13.0%,P=0.001)。
要点
- 30分钟压力支持通气SBT组成功拔管率82.3%,高于2小时T管SBT组的74.0%(差值8.2%,95%CI 3.4%-13.0%,P=0.001)。
- 两组再插管率分别为11.1%与11.9%(差值-0.8%,95%CI -4.8%至3.1%,P=0.63),无显著差异。
- 院内死亡率压力支持组10.4% vs T管组14.9%(差值-4.4%,95%CI -8.3%至-0.6%,P=0.02),90天死亡率13.2% vs 17.3%(HR 0.74,95%CI 0.55-0.99)。
核心结论
- 在机械通气患者中,30分钟压力支持通气的自主呼吸试验相比2小时T管通气可显著提高成功拔管率。
研究设计与样本
- 随机临床试验,2016年1月至2017年4月在西班牙18个重症监护病房纳入1153例机械通气至少24小时、判定可撤机的成人患者(平均年龄62.2岁,SD 15.7;女性428例,37.1%),随访至2017年7月。
主要发现
- 压力支持通气组成功拔管473例(82.3%),T管组428例(74.0%),差值8.2%(95%CI 3.4%-13.0%,P=0.001)。
- 压力支持组 vs T管组再插管率11.1% vs 11.9%(差值-0.8%,95%CI -4.8%至3.1%,P=0.63)。
- 压力支持组 vs T管组重症监护病房中位住院时间9天 vs 10天(均值差-0.3天,95%CI -1.7至1.1天,P=0.69)。
- 压力支持组 vs T管组院內中位住院时间24天 vs 24天(均值差1.3天,95%CI -2.2至4.9天,P=0.45)。
- 压力支持组 vs T管组院内死亡率10.4% vs 14.9%(差值-4.4%,95%CI -8.3%至-0.6%,P=0.02);90天死亡率13.2% vs 17.3%(差值-4.1%,95%CI -8.2%至0.01%,P=0.04;HR 0.74,95%CI 0.55-0.99)。
临床怎么用
- 作者认为这些发现支持在自主呼吸试验中采用更短、要求更低的通气策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Daily spontaneous breathing trials (SBTs) are the best approach to determine whether patients are ready for disconnection from mechanical ventilation, but mode and duration of SBT remain controversial. OBJECTIVE: To evaluate the effect of an SBT consisting of 30 minutes of pressure support ventilation (an approach that is less demanding for patients) vs an SBT consisting of 2 hours of T-piece ventilation (an approach that is more demanding for patients) on rates of successful extubation. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial conducted from January 2016 to April 2017 among 1153 adults deemed ready for weaning after at least 24 hours of mechanical ventilation at 18 intensive care units in Spain. Follow-up ended in July 2017. INTERVENTIONS: Patients were randomized to undergo a 2-hour T-piece SBT (n = 578) or a 30-minute SBT with 8-cm H2O pressure support ventilation (n = 557). MAIN OUTCOME AND MEASURES: The primary outcome was successful extubation (remaining free of mechanical ventilation 72 hours after first SBT). Secondary outcomes were reintubation among patients extubated after SBT; intensive care unit and hospital lengths of stay; and hospital and 90-day mortality. RESULTS: Among 1153 patients who were randomized (mean age, 62.2 [SD, 15.7] years; 428 [37.1%] women), 1018 (88.3%) completed the trial. Successful extubation occurred in 473 patients (82.3%) in the pressure support ventilation group and 428 patients (74.0%) in the T-piece group (difference, 8.2%; 95% CI, 3.4%-13.0%; P = .001). Among secondary outcomes, for the pressure support ventilation group vs the T-piece group, respectively, reintubation was 11.1% vs 11.9% (difference, -0.8%; 95% CI, -4.8% to 3.1%; P = .63), median intensive care unit length of stay was 9 days vs 10 days (mean difference, -0.3 days; 95% CI, -1.7 to 1.1 days; P = .69), median hospital length of stay was 24 days vs 24 days (mean difference, 1.3 days; 95% CI, -2.2 to 4.9 days; P = .45), hospital mortality was 10.4% vs 14.9% (difference, -4.4%; 95% CI, -8.3% to -0.6%; P = .02), and 90-day mortality was 13.2% vs 17.3% (difference, -4.1% [95% CI, -8.2% to 0.01%; P = .04]; hazard ratio, 0.74 [95% CI, 0.55-0.99]). CONCLUSIONS AND RELEVANCE: Among patients receiving mechanical ventilation, a spontaneous breathing trial consisting of 30 minutes of pressure support ventilation, compared with 2 hours of T-piece ventilation, led to significantly higher rates of successful extubation. These findings support the use of a shorter, less demanding ventilation strategy for spontaneous breathing trials. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02620358.
引用
- Subirà C, Hernández G, Vázquez A, et al. Effect of Pressure Support vs T-Piece Ventilation Strategies During Spontaneous Breathing Trials on Successful Extubation Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial. JAMA. 2019. PMID: 31184740. doi:10.1001/jama.2019.7234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。